Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the spinal cord stimulation devices market grown in recent years?
In recent years, the market size for spinal cord stimulation devices has seen considerable expansion. It is anticipated to swell from $2.74 billion in 2024 to $2.99 billion in 2025, with a compound annual growth rate (CAGR) of 9.01%. Factors contributing to this growth during the historic period include better clinical results and patient satisfaction, heightened awareness about alternatives for pain management, an increase in reimbursement support, a rise in clinical research and regulatory approvals, and growth in pain management clinics and centers.
How is the spinal cord stimulation devices market size expected to evolve during the forecast period?
In the coming years, the market for spinal cord stimulation devices is poised for substantial growth, with projections indicating a surge to $4.18 billion by 2029, reflecting a compound annual growth rate (CAGR) of 8.75%. This anticipated growth over the forecast period can be linked to a variety of factors – the increasing instances of chronic pain conditions, heightened demand for non-narcotic pain management alternatives, an expanding elderly population, favourable reimbursement policies, the growing acceptance of wireless and rechargeable devices, and an uptick in the understanding of neuromodulation therapies amongst medical professionals and patients. Key trends influencing the forecast period entail progress in minimally invasive technologies, developments in wireless and rechargeable devices, enhancements in frequency stimulation, the implementation of closed-loop feedback systems, the inclusion of wireless connectivity, breakthroughs in waveform options, and bespoke pain management algorithms.
Get your spinal cord stimulation devices market report here!
Which key drivers are propelling the spinal cord stimulation devices market’s growth?
The growth of the spinal cord stimulation devices market is anticipated to be propelled by the increasing instances of chronic pain. Chronic pain is a persistent discomfort that lasts for 12 weeks or more, often stemming from conditions like arthritis, neuropathy, or lower back pain. Lifestyle changes, aging population, chronic health problems, and injuries or traumas are among the factors contributing to the rise in chronic pain cases. Spinal Cord Stimulation (SCS) devices are instrumental in mitigating chronic pain by modifying pain signals using electrical impulses, hence offering respite for enduring conditions. For example, as per the Centres for Disease Control and Prevention, in November 2024, it was reported that 24.3% of adults admitted to having chronic pain, with 8.5% undergoing high-impact chronic pain, which summed up to 34.9% of the total chronic pain cases in 2023. Consequently, the increasing prevalence of chronic pain cases is fuelling the growth of the spinal cord stimulation devices market.
What are the market segments in the spinal cord stimulation devices industry?
The spinal cord stimulation devices market covered in this report is segmented –
1) By Type: Implantable Spinal Cord Stimulators, Non-Implantable Spinal Cord Stimulators
2) By Product Type: Rechargeable Devices, Non-Rechargeable Devices
3) By Application: Failed Back Surgery Syndrome, Complex Regional Pain Syndrome, Degenerative Disc Disease, Unsuccessful Disk Surgery, Other Applications
4) By End User: Hospitals, Ambulatory Surgical Centers, Neuro Clinics
Subsegments:
1) By Implantable Spinal Cord Stimulators: Rechargeable Spinal Cord Stimulators, Non-Rechargeable Spinal Cord Stimulators, Multi-Lead Implantable Spinal Cord Stimulators
2) By Non-Implantable Spinal Cord Stimulators: External Spinal Cord Stimulators, Wearable Spinal Cord Stimulators, Transcutaneous Spinal Cord Stimulators
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20964&type=smp
Which leading companies are shaping the growth of the spinal cord stimulation devices market?
Major companies operating in the spinal cord stimulation devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Nevro Corp., Bluewind Medical, NeuroPace Inc., Vertos Medical Inc., SPR Therapeutics Inc., Saluda Medical Pty Ltd., Stimwave Technologies Inc., Nuvectra Inc., Soterix Medical Inc., Synapse Biomedical, ONWARD Medical NV, NeuroSigma Inc., Nalu Medical Inc., Neurostim Technologies, SpineX Inc., Aleva Neurotherapeutics SA, GTX Medical BV
How are evolving market trends shaping spinal cord stimulation devices Strategies?
Major companies operating in the spinal cord stimulation devices market are focusing on developing advanced technologies, such as rechargeable spinal cord stimulation systems, to improve patient outcomes, enhance device longevity, and provide more personalized pain management solutions for individuals suffering from chronic pain. Rechargeable spinal cord stimulation (SCS) systems are advanced medical devices designed to manage chronic pain by delivering electrical impulses to the spinal cord. For instance, in December 2022, Abbott Laboratories, a US-based medical device manufacturing company, received the approval of the US Food and Drug Administration (FDA) for its Eterna spinal cord stimulation (SCS) system, a groundbreaking solution for chronic pain management. This innovative device combines a compact design with cutting-edge functionality, providing enhanced comfort and reduced physical burden for patients. Its rechargeable feature ensures long-term usability, minimizing the need for surgical replacements and promoting convenience. The system is equipped with precise stimulation capabilities, allowing for personalized pain relief tailored to individual patient needs. Its streamlined design facilitates minimally invasive implantation, reducing recovery time and improving overall patient outcomes.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20964
Which geographic areas are influencing the growth of the spinal cord stimulation devices market?
North America was the largest region in the spinal cord stimulation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spinal cord stimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Spinal Surgery Devices And Equipment Global Market Report 2025
Cerebrospinal Fluid Management CSF Devices And Equipment Global Market Report 2025
Spinal Imaging Global Global Market Report 2025
https://thebusinessresearchcompany.com/report/spinal-imaging-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
